Dynamic List Information
Dynamic List Data
Study Title
Phase II Trial Of Optune Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma
Sponsor Name
NovoCure Ltd.
NCT Number
NCT02743078
IDE Number
G150275
CMS Approval Date
2017-01-10
Clinical Trial Link
Category
B